Overview

Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

To evaluate long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone and DRSP/EE plus metformin on some cardiovascular risk factors in hyperinsulinemic PCOS patients

Phase:

Phase 3

Details

Lead Sponsor:

Catholic University of the Sacred Heart

Treatments:

Drospirenone and ethinyl estradiol combination
Ethinyl Estradiol
Metformin